Parsec Financial Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $1.92M | Buy |
46,983
+2,072
| +5% | +$89.5K | 0.08% | 132 |
|
|
2022
Q4 | $2.3M | Buy |
44,911
+754
| +2% | +$36.1K | 0.1% | 125 |
|
|
2022
Q3 | $1.93M | Sell |
44,157
-2,329
| -5% | -$113K | 0.1% | 130 |
|
|
2022
Q2 | $2.44M | Sell |
46,486
-12,706
| -21% | -$647K | 0.12% | 120 |
|
|
2022
Q1 | $3.06M | Buy |
59,192
+1,820
| +3% | +$94.4K | 0.13% | 111 |
|
|
2021
Q4 | $3.39M | Buy |
57,372
+1,165
| +2% | +$57.7K | 0.14% | 103 |
|
|
2021
Q3 | $2.66M | Buy |
56,207
+26,762
| +91% | +$1.19M | 0.11% | 117 |
|
|
2021
Q2 | $1.15M | Sell |
29,445
-1,300
| -4% | -$50.6K | 0.05% | 143 |
|
|
2021
Q1 | $1.11M | Buy |
30,745
+6,101
| +25% | +$217K | 0.06% | 140 |
|
|
2020
Q4 | $907K | Buy |
24,644
+9,428
| +62% | +$346K | 0.05% | 138 |
|
|
2020
Q3 | $530K | Buy |
15,216
+491
| +3% | +$17.2K | 0.03% | 158 |
|
|
2020
Q2 | $457K | Sell |
14,725
-1,580
| -10% | -$53.7K | 0.03% | 173 |
|
|
2020
Q1 | $505K | Sell |
16,305
-5,349
| -25% | -$182K | 0.04% | 158 |
|
|
2019
Q4 | $805K | Sell |
21,654
-1,107
| -5% | -$39.4K | 0.05% | 146 |
|
|
2019
Q3 | $776K | Sell |
22,761
-336
| -1% | -$12.2K | 0.05% | 145 |
|
|
2019
Q2 | $949K | Buy |
23,097
+2,346
| +11% | +$93.2K | 0.06% | 140 |
|
|
2019
Q1 | $836K | Sell |
20,751
-2,867
| -12% | -$115K | 0.05% | 146 |
|
|
2018
Q4 | $978K | Buy |
23,618
+787
| +3% | +$32.7K | 0.07% | 141 |
|
|
2018
Q3 | $955K | Buy |
22,831
+8,071
| +55% | +$311K | 0.06% | 142 |
|
|
2018
Q2 | $508K | Buy |
14,760
+896
| +6% | +$30.6K | 0.03% | 171 |
|
|
2018
Q1 | $467K | Buy |
13,864
+1
| +0% | +$34 | 0.03% | 181 |
|
|
2017
Q4 | $476K | Buy |
13,863
+69
| +0.5% | +$2.35K | 0.03% | 186 |
|
|
2017
Q3 | $467K | Buy |
13,794
+181
| +1% | +$5.82K | 0.03% | 187 |
|
|
2017
Q2 | $434K | Sell |
13,613
-47
| -0.3% | -$1.48K | 0.03% | 153 |
|
|
2017
Q1 | $443K | Sell |
13,660
-1,731
| -11% | -$54.6K | 0.04% | 146 |
|
|
2016
Q4 | $474K | Buy |
15,391
+429
| +3% | +$13.1K | 0.04% | 144 |
|
|
2016
Q3 | $481K | Buy |
14,962
+271
| +2% | +$9.06K | 0.04% | 143 |
|
|
2016
Q2 | $491K | Sell |
14,691
-104
| -0.7% | -$3.32K | 0.05% | 139 |
|
|
2016
Q1 | $416K | Buy |
14,795
+3,538
| +31% | +$101K | 0.04% | 139 |
|
|
2015
Q4 | $345K | Buy |
11,257
+1,013
| +10% | +$31.9K | 0.04% | 149 |
|
|
2015
Q3 | $305K | Sell |
10,244
-1,665
| -14% | -$53.4K | 0.03% | 149 |
|
|
2015
Q2 | $379K | Sell |
11,909
-210
| -2% | -$6.84K | 0.04% | 144 |
|
|
2015
Q1 | $400K | Sell |
12,119
-249
| -2% | -$7.92K | 0.04% | 139 |
|
|
2014
Q4 | $366K | Buy |
12,368
+4,523
| +58% | +$130K | 0.04% | 129 |
|
|
2014
Q3 | $220K | Buy |
7,845
+586
| +8% | +$16.4K | 0.02% | 153 |
|
|
2014
Q2 | $204K | Buy |
7,259
+489
| +7% | +$13.9K | 0.02% | 155 |
|
|
2014
Q1 | $206K | Sell |
6,770
-3,274
| -33% | -$97.6K | 0.02% | 150 |
|
|
2013
Q4 | $292K | Buy |
10,044
+2,004
| +25% | +$58.3K | 0.03% | 122 |
|
|
2013
Q3 | $219K | Buy |
+8,040
| New | +$219K | 0.03% | 126 |
|
Other funds holding PFE
Parsec Financial Management's PFE Position: Q1 2023 in Review
Parsec Financial Management increased its Pfizer (PFE) stake by 4.6% in Q1 2023, buying an estimated $89.5K and bringing the position to 46,983 shares worth $1.92M. The position accounts for 0.08% of the portfolio, ranked #132.
Parsec Financial Management first reported a position in PFE in Q3 2013 and has held it in 39 quarters since. The position peaked at $3.39M in Q4 2021. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.
- Parsec Financial Management held 46,983 shares of Pfizer worth $1.92M as of Q1 2023.
- Parsec Financial Management bought 2,072 Pfizer shares in Q1 2023, an estimated $89.5K.
- Pfizer made up 0.08% of Parsec Financial Management's portfolio in Q1 2023, its #132 holding.
- Parsec Financial Management first reported a position in Pfizer in Q3 2013 and has held it in 39 quarters since.
- Parsec Financial Management's Pfizer position peaked at $3.39M in Q4 2021.
- 3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.
Based on Parsec Financial Management's 13F filing for Q1 2023, filed 6 Apr 2023.